Literature DB >> 18504457

Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase.

Russell A DeBose-Boyd1.   

Abstract

3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase produces mevalonate, an important intermediate in the synthesis of cholesterol and essential nonsterol isoprenoids. The reductase is subject to an exorbitant amount of feedback control through multiple mechanisms that are mediated by sterol and nonsterol end-products of mevalonate metabolism. Here, I will discuss recent advances that shed light on one mechanism for control of reductase, which involves rapid degradation of the enzyme. Accumulation of certain sterols triggers binding of reductase to endoplasmic reticulum (ER) membrane proteins called Insig-1 and Insig-2. Reductase-Insig binding results in recruitment of a membrane-associated ubiquitin ligase called gp78, which initiates ubiquitination of reductase. This ubiquitination is an obligatory reaction for recognition and degradation of reductase from ER membranes by cytosolic 26S proteasomes. Thus, sterol-accelerated degradation of reductase represents an example of how a general cellular process (ER-associated degradation) is used to control an important metabolic pathway (cholesterol synthesis).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504457      PMCID: PMC2742364          DOI: 10.1038/cr.2008.61

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  81 in total

Review 1.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

2.  Degradation of 3-hydroxy-3-methylglutaryl-CoA reductase in endoplasmic reticulum membranes is accelerated as a result of increased susceptibility to proteolysis.

Authors:  T P McGee; H H Cheng; H Kumagai; S Omura; R D Simoni
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

3.  Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein.

Authors:  X Hua; A Nohturfft; J L Goldstein; M S Brown
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  In vivo examination of membrane protein localization and degradation with green fluorescent protein.

Authors:  R Y Hampton; A Koning; R Wright; J Rine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

5.  Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme.

Authors:  M Nakanishi; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

6.  Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol.

Authors:  D A Leonard; M A Kotarski; J E Tessiatore; M F Favata; J M Trzaskos
Journal:  Arch Biochem Biophys       Date:  1994-04       Impact factor: 4.013

7.  Inhibition of degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo by cysteine protease inhibitors.

Authors:  S Inoue; S Bar-Nun; J Roitelman; R D Simoni
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

8.  Developmental and metabolic regulation of the Drosophila melanogaster 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  F B Gertler; C Y Chiu; L Richter-Mann; D J Chin
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

9.  Distinct sterol and nonsterol signals for the regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  J Roitelman; R D Simoni
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

10.  Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum.

Authors:  J Roitelman; E H Olender; S Bar-Nun; W A Dunn; R D Simoni
Journal:  J Cell Biol       Date:  1992-06       Impact factor: 10.539

View more
  115 in total

1.  Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8.

Authors:  Youngah Jo; Peter C W Lee; Peter V Sguigna; Russell A DeBose-Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  The plasma membrane as a capacitor for energy and metabolism.

Authors:  Supriyo Ray; Adam Kassan; Anna R Busija; Padmini Rangamani; Hemal H Patel
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-25       Impact factor: 4.249

3.  Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations.

Authors:  Charina M Ramirez; Benny Liu; Amal Aqul; Anna M Taylor; Joyce J Repa; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2011-02-02       Impact factor: 5.922

4.  An endoplasmic reticulum (ER) membrane complex composed of SPFH1 and SPFH2 mediates the ER-associated degradation of inositol 1,4,5-trisphosphate receptors.

Authors:  Margaret M P Pearce; Duncan B Wormer; Stephan Wilkens; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

5.  Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase.

Authors:  Nicolle V Fernandes; Hoda Yeganehjoo; Rajasekhar Katuru; Russell A DeBose-Boyd; Lindsey L Morris; Renee Michon; Zhi-Ling Yu; Huanbiao Mo
Journal:  Exp Biol Med (Maywood)       Date:  2013-09-04

6.  Reep1 null mice reveal a converging role for hereditary spastic paraplegia proteins in lipid droplet regulation.

Authors:  Benoît Renvoisé; Brianna Malone; Melanie Falgairolle; Jeeva Munasinghe; Julia Stadler; Caroline Sibilla; Seong H Park; Craig Blackstone
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

7.  Intermittent hypoxia revisited: a promising non-pharmaceutical strategy to reduce cardio-metabolic risk factors?

Authors:  Guillaume Costalat; Frederic Lemaitre; Barbara Tobin; Gillian Renshaw
Journal:  Sleep Breath       Date:  2017-02-02       Impact factor: 2.816

Review 8.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

9.  INSIG1 influences obesity-related hypertriglyceridemia in humans.

Authors:  E M Smith; Y Zhang; T M Baye; S Gawrieh; R Cole; J Blangero; M A Carless; J E Curran; T D Dyer; L J Abraham; E K Moses; A H Kissebah; L J Martin; M Olivier
Journal:  J Lipid Res       Date:  2009-10-21       Impact factor: 5.922

Review 10.  Substrate-specific mediators of ER associated degradation (ERAD).

Authors:  Jeffrey L Brodsky; Richard J H Wojcikiewicz
Journal:  Curr Opin Cell Biol       Date:  2009-05-13       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.